These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 10867708

  • 1. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB, Weidenhaupt M, Choulier L, Chatellier J, Rauffer-Bruyère N, Altschuh D, Vernet T.
    J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH, Sandmaier BM, Stayton PS.
    Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
    Kabat EA, Wu TT.
    J Immunol; 1991 Sep 01; 147(5):1709-19. PubMed ID: 1908882
    [Abstract] [Full Text] [Related]

  • 7. The specificity properties that distinguish members of a set of homologous anti-digoxin antibodies are controlled by H chain mutations.
    Near RI, Bruccoleri R, Novotny J, Hudson NW, White A, Mudgett-Hunter M.
    J Immunol; 1991 Jan 15; 146(2):627-33. PubMed ID: 1898959
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A, Plückthun A.
    Biochemistry; 1998 Sep 22; 37(38):13120-7. PubMed ID: 9748318
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M, Stollar BD.
    J Immunol; 1995 Mar 01; 154(5):2198-208. PubMed ID: 7868893
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T, van Neer N, Sablon E, Desmet J, Celis L, Hoogenboom HR, Hufton SE.
    J Mol Biol; 2001 Jul 13; 310(3):591-601. PubMed ID: 11439026
    [Abstract] [Full Text] [Related]

  • 15. Unraveling the effect of changes in conformation and compactness at the antibody V(L)-V(H) interface upon antigen binding.
    Pellequer JL, Chen Sw, Roberts VA, Tainer JA, Getzoff ED.
    J Mol Recognit; 1999 Jul 13; 12(4):267-75. PubMed ID: 10440998
    [Abstract] [Full Text] [Related]

  • 16. An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
    Vargas-Madrazo E, Paz-García E.
    J Mol Recognit; 2003 Jul 13; 16(3):113-20. PubMed ID: 12833565
    [Abstract] [Full Text] [Related]

  • 17. In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.
    Figini M, Marks JD, Winter G, Griffiths AD.
    J Mol Biol; 1994 May 27; 239(1):68-78. PubMed ID: 8196048
    [Abstract] [Full Text] [Related]

  • 18. Somatic mutation in VH complementarity-determining region 2 and framework region 2: differential effects on antigen binding and Ig secretion.
    Wiens GD, Heldwein KA, Stenzel-Poore MP, Rittenberg MB.
    J Immunol; 1997 Aug 01; 159(3):1293-302. PubMed ID: 9233625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The role of interface framework residues in determining antibody V(H)/V(L) interaction strength and antigen-binding affinity.
    Masuda K, Sakamoto K, Kojima M, Aburatani T, Ueda T, Ueda H.
    FEBS J; 2006 May 01; 273(10):2184-94. PubMed ID: 16649995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.